Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AFINGEN
Emeryville, California, United Statesafingen.tech ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Preclinical
01
Overview
AFINGEN develops synthetic biology-based biotechnology platforms to enhance crop yields, improve plant traits such as growth rate and root structure, increase carbon capture by plants, reduce methane emissions from livestock through engineered feedstocks, and deliver phytomedicines to reduce agricultural emissions. The company’s work builds upon research from Lawrence Berkeley National Laboratory and the Joint BioEnergy Institute. It has received support from DOE Office of Science, USDA-NIFA, NASA SBIR/STTR programs. Key technologies include APFL for yield improvement and Climate Bio™ for climate impact mitigation.
- Modalities
- Synthetic biology platform cropsMetabolic engineering of plantsGenetic engineering of cropsSmall molecule (for anti-methane biomass technology)Biofuels production technologies
- Industry
- Non-Drug Biotech
02
Partnerships
Collaborations with Lawrence Berkeley National LaboratoryJoint BioEnergy Institutesupported by DOE Office of ScienceUSDA-NIFANASA SBIR/STTR programs
Beyond the preview
Go deeper on AFINGEN.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AFINGEN.